Summary of Action investigated Jusuru International (“Jusuru”), a multilevel marketing company that sells and markets supplements called Liquid BioCell and skin care products called Stromaderm, and found that the company and its distributors are engaged in a deceptive marketing campaign.

Specifically, compiled over 50 examples of unsubstantiated health and disease-treatment claims made by Jusuru distributors about the company’s products, such as being able to treat, cure, or alleviate the symptoms of rheumatoid arthritis, osteoarthritis, neuropathy, cancer, psoriasis, diabetes, fibromyalgia, and sciatica. also compiled over 40 examples of deceptive, atypical, and unsubstantiated income claims regarding the financial gains consumers will achieve by becoming distributors of Jusuru.

As a result of these findings, sent a warning letter to Jusuru on June 6, 2016 notifying it of’s findings and asking that the company remedy the deceptive marketing immediately.  On June 14, 2016, the company informed that it was taking immediate action to address the deceptive claims at issue, including, for example, the addition of an income disclaimer to marketing claims boasting financial rewards, as well as demanding that its distributors immediately remove inappropriate health claims.

Due to the company’s corrective actions and pledge to fully address the matter in short order, has not elevated its investigation by filing a complaint with the Federal Trade Commission at this time. However, will continue to monitor Jusuru, its progress, and future marketing materials to determine if further action is needed.

Print Friendly, PDF & Email


Leave a Reply

Back to Top ↑